Andrew Leask is a notable researcher with a distinguished career in the field of biomedical sciences. He has made significant contributions to the understanding of fibrotic diseases and the role of connective tissue growth factor (CTGF/CCN2). His research has provided valuable insights into the mechanisms underlying fibrosis and has influenced therapeutic approaches for fibrotic disorders. Andrew Leask is affiliated with a reputable academic institution and has published extensively in high-impact scientific journals. He is recognized for his expertise and has received various awards and honors for his contributions to the field.